Vacsera, the Holding Company for Biological Products and Vaccines, is Egypt's national vaccine manufacturer and one of Africa's oldest producers of biological products. Founded in 1881 and headquartered in Giza, the governmental holding company produces human and veterinary vaccines, sera, blood derivatives, and biotechnological medicines.
It operates through subsidiaries focused on vaccines, blood products, and related items to support national health security and regional supply. In June 2026, Vacsera signed a technical assistance agreement with EIB Global for a feasibility study on a new multi-product vaccine facility, with the overall project estimated at approximately €50 million and potential exports to other African countries.
Official website: vacsera.com
To provide comprehensive coverage, we aggregate data and news under the name Vacsera, encompassing the following company names, divisions, and related entities:
فاكسيرا, Holding Company for Biological Products and Vaccines SAE, and الشركة المصرية القابضة للمستحضرات الحيوية واللقاحات.
This list encompasses current and former names, alternate names, and key divisions associated with Vacsera, ensuring you can easily find all relevant information under a single, unified profile.
